Taysha Gene Therapies Stock (NASDAQ: TSHA)
|Day Range1.87 - 2.22||52 Wk Range1.68 - 12.17||Open / Close2.15 / 2.02||Float / Outstanding20.6M / 41.1M|
|Vol / Avg.108.8K / 108.2K||Mkt Cap83M||P/E-||50d Avg. Price3.57|
|Div / Yield-||Payout Ratio-||Total Float20.6M||EPS-0.84|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Taysha Gene Therapies (NASDAQ: TSHA) through any online brokerage.
The latest price target for Taysha Gene Therapies (NASDAQ: TSHA) was reported by Wedbush on Friday, August 12, 2022. The analyst firm set a price target for 5.00 expecting TSHA to rise to within 12 months (a possible 147.52% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Taysha Gene Therapies (NASDAQ: TSHA) is $2.02 last updated September 29, 2022, 8:00 PM UTC.
There are no upcoming dividends for Taysha Gene Therapies.
Taysha Gene Therapies’s Q3 earnings are confirmed for Wednesday, November 9, 2022.
There is no upcoming split for Taysha Gene Therapies.
Taysha Gene Therapies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.